The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation.

Background:Implementing integrated HIV and buprenorphine/naloxone treatment requires cost estimates to plan and obtain funding.Methods:We identified costs incurred at HIV clinical sites participating in a cross-site evaluation of integrated care that followed patients for 1 year. Costs include labor